Irvine Medical Center
Orange, California 92868
0 studies enrolling now · 3 studies all time
What they study most
Any Solid Tumor, Breast Cancer, Colon Cancer, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Medullary Thyroid Cancer, Mycosis Fungoides/Sezary Syndrome, Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Other Solid Tumors With Evidence of Activating RET Alteration, Pancreatic Cancer, Papillary Thyroid Cancer
Studies at this site
- IPH4102/Lacutamab Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma — Completed
- A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) — Running, not enrolling
- Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation — APPROVED_FOR_MARKETING